TSN:NYSETyson Foods, Inc. Analysis
Data as of 2026-03-11 - not real-time
$60.24
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
Tyson Foods (TSN) is trading at $60.24, which sits below its 20‑day SMA of $63.23 but above the 200‑day SMA of $56.77, indicating a mixed short‑term technical picture within a longer‑term bullish trend. The RSI of 36.6 suggests the stock is approaching oversold territory, while a bearish MACD histogram reinforces near‑term downside pressure. Support around $59.78 is holding, but resistance near $65.95 looms, limiting upside unless a breakout occurs. Fundamentally, the company’s PE ratio of 107.6 and forward PE of 13.6 highlight severe overvaluation relative to its DCF fair value of $36.57, implying a price discount of over 40% to intrinsic value. Margins are thin (gross margin 6.2%, operating margin 2.9%) and profit margin is only 0.36%, with ROE at 1.3%, underscoring weak earnings generation. The dividend yield of 3.39% looks attractive, but a payout ratio of 359% is clearly unsustainable, raising concerns about future cuts. A recent $500 million senior notes offering adds debt to an already high leverage profile (debt‑to‑equity 46), while the low beta of 0.33 and 30‑day volatility of ~21% suggest limited price swings.
Given the defensive consumer sector backdrop, low liquidity risk, and increasing volume, the stock may hold its current level in the short run, but the combination of overvaluation, fragile profitability, and dividend sustainability issues point to limited upside and potential downside over medium to long horizons.
Given the defensive consumer sector backdrop, low liquidity risk, and increasing volume, the stock may hold its current level in the short run, but the combination of overvaluation, fragile profitability, and dividend sustainability issues point to limited upside and potential downside over medium to long horizons.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support at $59.78
- Oversold RSI indicating possible rebound
- High dividend payout ratio raising near‑term uncertainty
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Persistent overvaluation relative to DCF
- Thin operating margins and low ROE
- Increasing debt load from recent senior notes issuance
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Fundamental overvaluation and unsustainable dividend
- Weak profitability trends and high leverage
- Potential for price correction toward intrinsic value
Key Metrics & Analysis
Financial Health
Revenue Growth5.10%
Profit Margin0.36%
P/E Ratio107.6
ROE1.26%
ROA2.17%
Debt/Equity46.04
P/B Ratio1.2
Op. Cash Flow$2.1B
Free Cash Flow$1.2B
Technical Analysis
TrendBullish
RSI36.6
Support$59.78
Resistance$65.95
MA 20$63.23
MA 50$62.05
MA 200$56.77
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91
Valuation
Fair Value$36.57
Target Price$69.08
Upside/Downside14.68%
GradeOvervalued
TypeValue
Dividend Yield3.39%
Risk Assessment
Beta0.33
Volatility20.88%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.